Protective Effects of Aspirin from Cardiac Hypertrophy and Oxidative Stress in Cardiomyopathic Hamsters

Figure 1

Time course of body weight (a) and the cardiac ventricular weight (mg)/body weight (g) ratio (b) in control (Cntrl) and cardiomyopathic (CM) hamster treated with placebo or 100 mg/kg/day acetylsalicylic acid (+ASA). **𝑃<0.01 versus control, ⁺𝑃<0.05, ⁺⁺𝑃<0.01 versus CM hamsters.

(a)

(b)